Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines

This publication has 16 references indexed in Scilit:

• Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
• Alkyllysophospholipid ET‐18‐OCH₃ acts as an activator of protein kinase C in HL‐60 cells
  FEBS Letters, 1991
• Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1990
• Hexadecylphosphocholine: a new and selective antitumor drug
  Cancer Treatment Reviews, 1990
• Hexadecylphosphocholine, a New Ether Lipid Analogue Studies on the Antineoplastic Activity in Vitro and in Vivo
  Acta Oncologica, 1988
• Inhibition of Na,K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440
  Biochemical and Biophysical Research Communications, 1988
• HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form
  Biochemical and Biophysical Research Communications, 1988
• Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)
  European Journal of Cancer and Clinical Oncology, 1988
• The molecular heterogeneity of protein kinase C and its implications for cellular regulation
  Nature, 1988
• Studies and Perspectives of Protein Kinase C
  Science, 1986